How Gut Peptide Hormones Control Appetite and Drive Obesity Treatment Advances | Research

The takeaway

Gut peptide hormones are central to appetite regulation, and dual or triple receptor agonist drugs targeting these peptides show additive weight loss benefits in early clinical trials.

Multi-target
Dual and triple gut peptide receptor agonists show additive weight loss benefits in early clinical trials

What the researchers found

Combining multiple gut peptide receptor agonists (dual or triple) produces additive weight loss and glycemic improvement, replicating the hormonal changes seen after bariatric surgery.

Why it matters

Understanding why gut hormones change in obesity and after weight loss explains both why diets fail and why bariatric surgery succeeds, guiding development of next-generation weight loss drugs.

The numbers in context

Covers ghrelin, GLP-1, PYY, GIP, CCK, oxyntomodulin changes in obesity and post-surgery; dual/triple agonists in early trials

How the study worked

Narrative review of published literature on gut hormone physiology, adaptations in obesity, and emerging pharmacological therapies.

Who was studied

N/A (literature review covering obesity and bariatric surgery research)

What this study cannot tell us

Narrative review without systematic methodology. Many dual/triple agonist data cited were from early-phase trials.

How to read the evidence

Comprehensive narrative review with strong mechanistic basis but some cited therapies still in early development.

When this study was published

Published in 2020. The multi-agonist approach described has since advanced, with tirzepatide (dual GIP/GLP-1 agonist) receiving FDA approval.

The bigger picture

This review contextualizes the rapid development of GLP-1-based and multi-target weight loss drugs, explaining the gut hormone science behind the revolutionary shift in obesity treatment.

Questions still open

Which combination of gut peptide targets produces the best weight loss with fewest side effects?
Can gut hormone-based therapies fully replicate bariatric surgery's metabolic benefits?
Do gut hormone changes after weight loss eventually normalize?

Common questions

Why does weight come back after dieting?

After weight loss, gut hormones change in ways that actively promote weight regain. Hunger hormones increase, satiety signals decrease, and the body fights to restore its previous weight. This is why purely behavioral approaches often fail long-term.

What are dual and triple agonist weight loss drugs?

These medications simultaneously activate receptors for two or three gut hormones, such as GLP-1 and GIP together. By targeting multiple pathways at once, they produce greater weight loss than single-target drugs, mimicking the hormonal changes seen after bariatric surgery.

Read the original research

The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity.

Current obesity reports, 9(3), 255-271

View on PubMed ↗Publisher’s paper ↗

Citation

Koliaki, Chrysi; Liatis, Stavros; Dalamaga, Maria; Kokkinos, Alexander. (2020). The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity.. Current obesity reports, 9(3), 255-271. https://doi.org/10.1007/s13679-020-00396-9